RosiridinCAS# 100462-37-1 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 100462-37-1 | SDF | Download SDF |
| PubChem ID | 10314695 | Appearance | Oil |
| Formula | C16H28O7 | M.Wt | 332.39 |
| Type of Compound | Monoterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | (2R,3R,4S,5S,6R)-2-[(2E)-4-hydroxy-3,7-dimethylocta-2,6-dienoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | ||
| SMILES | CC(=CCC(C(=CCOC1C(C(C(C(O1)CO)O)O)O)C)O)C | ||
| Standard InChIKey | PBPYEEMQIFDGSQ-MIYBPCGNSA-N | ||
| Standard InChI | InChI=1S/C16H28O7/c1-9(2)4-5-11(18)10(3)6-7-22-16-15(21)14(20)13(19)12(8-17)23-16/h4,6,11-21H,5,7-8H2,1-3H3/b10-6+/t11?,12-,13-,14+,15-,16-/m1/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Rosiridin has cardioprotective activity. |
| In vitro | The determination of rosiridin in effect extracts of anti-coronary atherosclerotic heart disease of Rhodiola rosea by HPLC[Reference: WebLink]Journal of Xinjiang Medical University,2007, 30(2):127-9.To develop an assay method for determining the concentrations of Rosiridin in effect extracts of anti-coronary atherosclerotic heart disease of Rhodiola rosea. |
| Structure Identification | Chem Pharm Bull (Tokyo). 2008 May;56(5):695-700.Reinvestigation of absolute stereostructure of (-)-rosiridol: structures of monoterpene glycosides, rosiridin, rosiridosides A, B, and C, from Rhodiola sachalinensis.[Pubmed: 18451561]Three new (-)-rosiridol glycosides, rosiridosides A, B, and C, were isolated from the roots of Rhodiola sachalinensis together with Rosiridin [(-)-rosiridol 1-O-beta-D-glucopyranoside]. In the course of the structure elucidation of those new glycosides, the absolute configuration of the 4-position in (-)-rosiridol was reinvestigated. On the basis of the application of the modified Mosher's method for (-)- and (+)-rosiridol derivatives, the absolute configuration of the 4-position in (-)-rosiridol should be revised to be S orientation from the recently assigned R form, so that the absolute stereostructures of rosiridosides A, B, and C and Rosiridin were determined. |
Rosiridin Dilution Calculator
Rosiridin Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.0085 mL | 15.0426 mL | 30.0851 mL | 60.1703 mL | 75.2129 mL |
| 5 mM | 0.6017 mL | 3.0085 mL | 6.017 mL | 12.0341 mL | 15.0426 mL |
| 10 mM | 0.3009 mL | 1.5043 mL | 3.0085 mL | 6.017 mL | 7.5213 mL |
| 50 mM | 0.0602 mL | 0.3009 mL | 0.6017 mL | 1.2034 mL | 1.5043 mL |
| 100 mM | 0.0301 mL | 0.1504 mL | 0.3009 mL | 0.6017 mL | 0.7521 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- FFN 511
Catalog No.:BCC7799
CAS No.:1004548-96-2
- 1-EBIO
Catalog No.:BCC6904
CAS No.:10045-45-1
- Dihydroresveratrol 3-O-glucoside
Catalog No.:BCN5821
CAS No.:100432-87-9
- Cobicistat (GS-9350)
Catalog No.:BCC2271
CAS No.:1004316-88-4
- Boric acid
Catalog No.:BCC7592
CAS No.:10043-35-3
- Lercanidipine
Catalog No.:BCC5239
CAS No.:100427-26-7
- Danshinspiroketallactone
Catalog No.:BCN3754
CAS No.:100414-80-0
- Sodium Picosulfate
Catalog No.:BCC4845
CAS No.:10040-45-6
- GSK 1562590 hydrochloride
Catalog No.:BCC8010
CAS No.:1003878-07-6
- Calcium chloride dihydrate
Catalog No.:BCC7582
CAS No.:10035-04-8
- Curcumenone
Catalog No.:BCN3008
CAS No.:100347-96-4
- L(+)-Rhamnose monohydrate
Catalog No.:BCN8368
CAS No.:10030-85-0
- Gastrin I (human)
Catalog No.:BCC5958
CAS No.:10047-33-3
- Sterigmatocystin
Catalog No.:BCN6885
CAS No.:10048-13-2
- Blasticidin A
Catalog No.:BCN1830
CAS No.:100513-53-9
- TCS 2002
Catalog No.:BCC6074
CAS No.:1005201-24-0
- Aeruginolactone
Catalog No.:BCN3695
CAS No.:1005208-88-7
- Gelomulide N
Catalog No.:BCN6641
CAS No.:1005212-02-1
- CVT 10216
Catalog No.:BCC5606
CAS No.:1005334-57-5
- LCL161
Catalog No.:BCC1691
CAS No.:1005342-46-0
- Tirasemtiv
Catalog No.:BCC5183
CAS No.:1005491-05-3
- Monomethylsulochrin
Catalog No.:BCN7255
CAS No.:10056-14-1
- TC ASK 10
Catalog No.:BCC6301
CAS No.:1005775-56-3
- TAK-593
Catalog No.:BCC5142
CAS No.:1005780-62-0
Reinvestigation of absolute stereostructure of (-)-rosiridol: structures of monoterpene glycosides, rosiridin, rosiridosides A, B, and C, from Rhodiola sachalinensis.[Pubmed:18451561]
Chem Pharm Bull (Tokyo). 2008 May;56(5):695-700.
Three new (-)-rosiridol glycosides, rosiridosides A, B, and C, were isolated from the roots of Rhodiola sachalinensis together with Rosiridin [(-)-rosiridol 1-O-beta-D-glucopyranoside]. In the course of the structure elucidation of those new glycosides, the absolute configuration of the 4-position in (-)-rosiridol was reinvestigated. On the basis of the application of the modified Mosher's method for (-)- and (+)-rosiridol derivatives, the absolute configuration of the 4-position in (-)-rosiridol should be revised to be S orientation from the recently assigned R form, so that the absolute stereostructures of rosiridosides A, B, and C and Rosiridin were determined.
